Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank87
3Y CAGR+2.1%
5Y CAGR+10.8%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+2.1%/yr
vs +10.2%/yr prior
5Y CAGR
+10.8%/yr
Recent deceleration
Acceleration
-8.1pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$37.43M-11.1%
2024$42.12M-19.0%
2023$52.00M+48.0%
2022$35.13M+34.6%
2021$26.11M+16.6%
2020$22.39M+1.5%
2019$22.07M-7.4%
2018$23.83M-11.5%
2017$26.91M+0.2%
2016$26.85M-